Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma
about
Role of surgery in colorectal cancer liver metastasesDevelopment of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panelLocoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver.Hepatic intra-arterial versus intravenous fotemustine in patients with liver metastases from uveal melanoma (EORTC 18021): a multicentric randomized trial.Management of stage IV rectal cancer: palliative options.Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone?Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results?Colorectal hepatic metastasis: Evolving therapies.Initial hepatic artery infusion and systemic chemotherapy for asymptomatic colorectal cancer with un-resectable liver metastasis.Liver-directed conversion therapy in metastatic colon cancer.A Case Report of Long-Term Survival following Hepatic Arterial Infusion of L-Folinic Acid Modulated 5-Fluorouracil Combined with Intravenous Irinotecan and Cetuximab Followed by Hepatectomy in a Patient with Initially Unresectable Colorectal Liver MCurrent state of surgical treatment of liver metastases from colorectal cancerProspective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases.Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials.Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.Preoperative imaging for hepatic resection of colorectal cancer metastasis.What is the potential role of hepatic arterial infusion chemo-therapy in the current armamentorium against colorectal cancer.Integrating Chemotherapy into the Management of Oligometastatic Colorectal Cancer: Evidence-Based Approach Using Clinical Trial FindingsSegmental and lobar administration of drug-eluting beads delivering irinotecan leads to tumour destruction: a case-control series.Modern prospection for hepatic arterial infusion chemotherapy in malignancies with liver metastasesFirst-line treatment with hepatic arterial infusion plus capecitabine vs capecitabine alone for elderly patients with unresectable colorectal liver metastasesPartial response after transcatheter arterial infusion chemotherapy in a patient with systemic chemotherapy-resistant unresectable colon cancer and hepatic metastasis: (case report).A phase I trial of isolated hepatic perfusion (IHP) using 5-FU and oxaliplatin in patients with unresectable isolated liver metastases from colorectal cancer.Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).Liver angulometry: a simple method to estimate liver volume and ratios.Young patients with synchronous colorectal liver metastases.Regional liver therapy using oncolytic virus to target hepatic colorectal metastases.Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases.Advances in regional chemotherapy of the liver.Arterial therapies of colorectal cancer metastases to the liver.Clinical significance of and future perspectives for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer.Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab.Hepatic resection for colorectal metastases.Hepatic arterial infusion pump chemotherapy for colorectal liver metastases: an old technology in a new era.Regional hepatic therapies: an important component in the management of colorectal cancer liver metastases.Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review.Colorectal cancer with potentially resectable hepatic metastases: optimizing treatment.Liver-directed therapies in metastatic colorectal cancer.
P2860
Q26830444-DE88C3A9-CD35-447A-B77B-05807B1DEF11Q27014926-699898BB-36F8-482A-B9EE-A296E00AB257Q30415022-106ED86D-F2B1-427E-8738-065D3E73ED2FQ33390290-ED1549E3-A69F-4E9B-B509-7E0BA8EB4B01Q33413244-55DBD300-BE96-45CE-B124-FE09A15834B9Q33849034-1B922D16-7413-48FC-B705-079E00B4C63AQ34207776-D88A526A-F68B-4733-B7FF-2B3D46438E24Q34630274-4322CFA9-203D-4CF5-8900-063872B9D50EQ34663557-628F0D7F-26D7-4462-9852-1A153A418784Q35173700-C9DFDE7B-7FF2-409B-B5CB-60B032FCE832Q35419309-7EF5E35B-F4F6-4379-A291-01D0118BAB70Q35625828-5A76E5C4-5DF3-435E-A750-0A2A7336E875Q35653302-585B6362-B95C-446F-95AE-2285F6013BC4Q35761121-A276FE6D-68C3-4F4A-948E-D45A01895B05Q35862775-E8618F5F-B037-4B4E-BDD5-AB160233EC23Q35892542-B0AC951F-AD29-4669-A639-081DF89DFEEBQ36083102-7B15333D-1AB0-4147-9F27-FF61273D5725Q36097250-98B11A40-AE2F-49DE-BFEB-ABADC3F5628DQ36097254-934F3115-6013-4C57-964D-B5E82CC9DDE8Q36396031-69D67E46-F0F7-4238-9482-2E40A42EA6BFQ36498492-54F975A8-3233-4E9B-AFF5-6251E9E6AEB3Q36838134-6A242BBF-E745-4EAA-BA23-7FB3BF7FCAF8Q36843737-7C4CF3E7-8BD4-4F1D-AEE9-EFAC8C04CB75Q37116695-BDAE621F-8986-4986-B08C-BE59C9C8F7C5Q37254998-2293BFAE-4AC2-41C8-B8B9-EB6A0231B526Q37308725-1EB762DF-EDBC-4708-BC14-239AFB7FFE66Q37350315-2985789C-3827-4B58-9F36-0F87558A0D10Q37445913-22E2D90F-4DA1-4364-952F-57A557DE254FQ37759934-D36A36A9-0647-4A32-A588-7788AFA92F6BQ37821853-80F9E873-2832-471C-B5D3-E9A0E830A4C6Q37867126-8D1780B9-8A32-4C5E-B2CF-4BF15D3F916EQ37890914-240311B1-004B-4FF3-91C4-390D0167EA9CQ38059122-F5163E22-2E70-42DC-B971-F526CB9FACE2Q38155097-AC9D8F5D-2BEF-4EDD-817D-373DE138C6C6Q38169594-55008DA1-928F-4C7B-B99F-CE3519799B6EQ38187647-1D5A3D9A-6BFF-4385-A641-8D7E024A57C6Q38191225-DBC8CF65-1E40-4E25-9C8C-C18DC94888E7Q38206730-CD002C39-F099-4CCE-8A2B-FF2D65591FC0Q38240439-CCE9AFB4-E6D4-4174-A7F8-44729887929CQ38256165-34B45D22-F52C-40C3-96A4-EBC51F530A59
P2860
Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Conversion to resectability us ...... ases from colorectal carcinoma
@en
type
label
Conversion to resectability us ...... ases from colorectal carcinoma
@en
prefLabel
Conversion to resectability us ...... ases from colorectal carcinoma
@en
P2093
P2860
P356
P1476
Conversion to resectability us ...... ases from colorectal carcinoma
@en
P2093
Dina Patel
Fidel D Huitzil Melendez
Lawrence H Schwartz
Marinela Capanu
Michael D'Angelica
Nancy E Kemeny
Philip B Paty
William R Jarnagin
P2860
P304
P356
10.1200/JCO.2008.20.1301
P407
P50
P577
2009-05-26T00:00:00Z